2024-11-17 05:53:38
The FDA has approved the CSF-1R inhibitor Pimicotinib (ABSK021) of Abbisko Therapeutics to enter the Pivotal Global Multi-center Phase III Clinical Trial
Corporate/ 2023-07-24
The FDA has approved the CSF-1R inhibito...

This is the first-ever global phase III trial for TGCT approved by NMPA and FDA. Pimicotinib (ABSK021)was granted BTD by FDA and CDE,disco...

Bolstering Healthcare Quality in Malaysia with Renowned Flagship Hospitals
Health/ 2023-07-22
Bolstering Healthcare Quality in Malaysi...

Malaysia\'s position as a safe and trusted destination for high-quality healthcare services is reinforced with the debut of flagship medical...

CUSMail

CusMail provide the Latest News , Business and Technology News Release service. Most of our news is paid for distribution to meet global marketing needs. We can provide you with global market support.

© CUSMAIL. All Rights Reserved. Operate by Paid Release